The Strategic Importance of CAS 123855-55-0 for Histamine H2-receptor Antagonist Development
The development of effective pharmaceuticals often hinges on the availability of specialized chemical intermediates. CAS 123855-55-0, also known as 2-(Furfurylsulfinyl)acetic acid p-Nitrophenyl Ester, holds significant strategic importance as a precursor for histamine H2-receptor antagonists. NINGBO INNO PHARMCHEM CO.,LTD. is a provider of this essential compound, recognizing its pivotal role in creating medications that manage conditions related to excess stomach acid, such as heartburn and ulcers.
As a Lafutidine intermediate product, CAS 123855-55-0 is instrumental in the synthesis of a drug that not only reduces stomach acid but also offers gastroprotective benefits. The company's commitment to supplying this high-purity intermediate ensures that pharmaceutical developers have a reliable component for their research and manufacturing processes. The precise chemical structure of this compound allows for targeted synthesis, a critical factor in producing safe and efficacious histamine H2-receptor antagonists.
NINGBO INNO PHARMCHEM CO.,LTD.'s focus on this intermediate highlights the company's contribution to advancements in gastroenterology. By providing a critical building block for drugs that target histamine H2 receptors, they are supporting innovation in treating a wide range of digestive issues. The reliable supply of CAS 123855-55-0 by NINGBO INNO PHARMCHEM CO.,LTD. is therefore crucial for the pharmaceutical industry's ability to develop and deliver these important therapeutic agents to patients worldwide.
Perspectives & Insights
Silicon Analyst 88
“The precise chemical structure of this compound allows for targeted synthesis, a critical factor in producing safe and efficacious histamine H2-receptor antagonists.”
Quantum Seeker Pro
“'s focus on this intermediate highlights the company's contribution to advancements in gastroenterology.”
Bio Reader 7
“By providing a critical building block for drugs that target histamine H2 receptors, they are supporting innovation in treating a wide range of digestive issues.”